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Live vaccines have emerged as one of the most potentially cost-effective measures for the control of bovine
neosporosis. Previous studies have shown that Nc-Spain 1H is a naturally attenuated isolate of Neospora caninum
and that immunisation with live Nc-Spain 1H tachyzoites generated a protective immune response in mice. The
aim of this study was to evaluate the safety and efficacy of immunisation in cattle. N. caninum-seronegative heifers were
immunised subcutaneously twice with 107 live Nc-Spain 1H tachyzoites prior to artificial insemination. No adverse
reactions or negative effects on reproductive parameters were recorded following immunisation. In immunised and
non-challenged heifers, no foetal deaths were observed, and none of the calves was congenitally infected. The efficacy
against N. caninum-associated foetal death and vertical transmission was determined after challenge with high doses of
the Nc-1 isolate at 70 and 135 days of gestation, respectively. After the challenge in early gestation, the immunisation
induced a protection of 50% against foetal death. In addition, the microsatellite analysis performed in PCR-positive tissue
samples from foetuses that died after challenge infection showed that the profiles corresponded to the challenge isolate
Nc-1. A degree of protection against vertical transmission was observed after challenge at mid-gestation; calves from
immunised heifers showed significantly lower pre-colostral Neospora-specific antibody titres than calves from the
non-immunised/challenge group (P < 0.05). Strong antibody and interferon gamma responses were induced in the
immunised heifers. This study indicates that the immunisation before pregnancy with the Nc-Spain 1H vaccine isolate
appeared to be safe and reduced the occurrence of N. caninum-associated abortion and vertical transmission in
experimentally infected cattle. In light of these encouraging results, the next step for testing this live attenuated
candidate should be the assessment of its efficacy and safety in naturally infected cattle.Introduction
Bovine neosporosis is one of the major parasitic diseases
causing reproductive failure in cattle worldwide. Unfor-
tunately, there are no drugs available to prevent N. cani-
num-associated abortion and vertical transmission, and
control of this disease relies on effective management. In
this context, a previous economic model recommended
vaccination as the most cost-efficient alternative, even* Correspondence: luis.ortega@vet.ucm.es
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distribution, and reproduction in any mediumwhen an only partially effective vaccine was employed
[1,2]. While several approaches have been developed to
obtain vaccines against N. caninum, those methods
based on attenuated isolates appear to be the most
promising candidates for feasible live vaccines [3,4].
Recently, a new N. caninum isolate (Nc-Spain 1H) was
obtained from the brain of a clinically healthy but con-
genitally infected calf and demonstrated to have reduced
virulence by means of in vitro and in vivo experiments.
The Nc-Spain 1H isolate displayed lower invasion and
proliferation efficiency in cell culture than did the Nc-1
isolate [5,6]. The pathogenicity of Nc-Spain 1H was ex-
amined in BALB/c mice; in a dose-titration experiment,entral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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mortality, and no parasites were detected in the brains
of these mice during the chronic stage, even in those
given doses of 107 tachyzoites. In a pregnant mouse
model, the offspring survival rate from Nc-Spain 1H-
infected dams was almost 100%, and N. caninum was
detected in only one pup [5]. Furthermore, the inocula-
tion of Nc-Spain 1H tachyzoites in cattle at 70 days of
gestation did not induce foetal death [7]. A recent study
also proved that this isolate was highly efficacious in
preventing congenital and cerebral neosporosis in mice
[8]. These data indicate that Nc-Spain 1H is a low-
virulence isolate, and, consequently, may be a safe candi-
date for live-vaccine development in cattle.
Therefore, the aim of this study was to evaluate the
safety and efficacy of the Nc-Spain1H isolate at prevent-
ing foetal death and vertical transmission in cattle after a
heterologous challenge at early and mid-gestation.
Materials and methods
Ethical statement
All of the protocols involving animals were approved by
the Animal Research Committee of the Complutense
University, Madrid, Spain in compliance with the pro-
ceedings described in the Regulation of Internal Regime
for Animal Research Committee (published at BOUC,
no. 2, at 9 February 2006) and the EU legislation (Coun-
cil Directive 86/609/EEC).
Parasites
Live tachyzoites from the N. caninum Nc-Spain 1H isolate
[5] and from the Nc-1 isolate [9] were used for the im-
munisation and for the heterologous challenge, respect-
ively. Both isolates were maintained in vitro by continuous
passage in MARC-145 cell monolayers as previously de-
scribed [10] to ensure healthy and actively dividing pa-
rasites. To preserve its original biological properties, the
Nc-Spain 1H isolate was subjected to a limited number of
culture passages (passage no. 9–17). The Nc-1 isolate,
which had been maintained in Vero cells for long-term
passages, was propagated under new culture conditions
using MARC-145 cells. This shift from Vero cells to a new
cell line was expected to minimise potential changes in
the biological characteristics of the parasite due to pro-
longed cell culture maintenance [10]. The Nc-1 tachy-
zoites were inoculated in cattle after a limited number of
culture passages in MARC-145 cells (passage no. 15).
Parasite viability and numbers were determined by trypan
blue exclusion followed by three aliquot countings in a
Neubauer chamber. The infection dose was adjusted with
phosphate-buffered saline (PBS) to the required doses for
immunisation or challenge in a final volume of 5 mL per
heifer. The parasites were administered to cattle within 2 h
of harvesting from the tissue culture.Nc-1 tachyzoites used for DNA extraction and as anti-
gens for specific IFNγ detection and ELISA techniques
were washed three times in sterile PBS (pH 7.4). Host
cell debris was separated by first passing the mixture
through a 25-gauge needle then through PD-10 columns
(GE Healthcare Life Sciences, Uppsala, Sweden) [11]. Cell-
free Nc-1 tachyzoites were pelleted by centrifugation
(600 × g, 10 min) and frozen at −80 °C until use. To obtain
N. caninum soluble protein antigens, purified tachyzoites
were suspended in 1 mL of 10 mM Tris–HCl containing
2 mM phenylmethylsulphonyl fluoride (Sigma, St. Louis,
MO, USA) and were disrupted by sonication (Sonifier 450,
Branson Ultrasonic, Danbury, CT, USA) in an ice bath.
Cell debris and unlysed cells were removed by centrifuga-
tion (10 000 × g, 20 min, 4 °C). The protein concentration
of the supernatant was quantified using the Micro BCA
protein assay (Pierce, Rockford, IL, USA), and the super-
natant was aliquoted and frozen at −80 °C.
Animals and experimental design
Forty-eight Holstein Friesian heifers aged 16–24 months
and negative for Brucella abortus, Leptospira spp., Infec-
tious Bovine Rhinotracheitis Virus (IBRV) and Bovine
Viral Diarrhoea Virus (BVDV) were selected from the
same dairy farm. Heifers were tested twice by ELISA
(CIVTEST BOVIS NEOSPORA, HIPRA, Girona, Spain)
for evidence of N. caninum exposure, and were all found
to be seronegative. Before starting the experiment, the
heifers were vaccinated against BVDV and IBRV (HIPRA-
BOVIS® 4, HIPRA, Girona, Spain).
While at the dairy farm, 26 heifers were randomly
selected and subcutaneously (sc) immunised twice at
4-week intervals with 107 tachyzoites of the Nc-Spain
1H isolate in PBS over the left prescapular lymph node
prior to artificial insemination; the remaining heifers
received PBS. All of the animals were synchronised to
be in oestrus at the time of the booster immunisation.
Synchronisation was accomplished by administering two
intramuscular injections of a synthetic PGF2α analogue
(Prosolvin, MDS Animal Health, Salamanca, Spain) at
11-day intervals. At 72 h after the last injection, the ani-
mals were artificially inseminated (AI) with semen from
a N. caninum-seronegative bull. Booster immunisation
was conducted at the time of the AI. Pregnancy was
confirmed by ultrasonography in 31 heifers on days 35
and 57 after AI. After the diagnosis of pregnancy, 27
immunised and non-immunised pregnant heifers were
moved to an experimental farm at Complutense Univer-
sity of Madrid (UCM).
Animals maintained in experimental conditions were
allocated into 6 experimental groups (groups 1–4 with 5
animals, group 5 with 4 animals and group 6 with 3 ani-
mals) as described in Table 1. Groups 1, 2 and 4 were
sc-immunised with the Nc-Spain 1H isolate prior to AI.
Table 1 Summary of groups
Groupa
Immunisation Challenge time Challenge dose Number
of
animals
(Nc-Spain 1H tachyzoites)b (days of gestation) (Nc-1)
1 (Immunised/non-challenged) 107 - - 5
2 (Immunised/70-challenged) 107 70 107 5
3 (Non-immunised/70-challenged) None 70 107 5
4 (Immunised/135-challenged) 107 135 4 × 108 5
5 (Non-immunised/135-challenged) None 135 4 × 108 4
6 (Non-immunised/non-challenged) None - - 3
7 (Immunised/non-challenged) 107 - - 11
8 (Non-immunised/non-challenged) None - - 10
a Groups 1 to 6 were maintained at the experimental farm (UCM), whereas groups 7 and 8 were kept at the dairy farm throughout the experiment.
b Heifers were subcutaneously immunised twice at 4-week intervals prior to artificial insemination.
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2 and 3 after intravenous (iv) challenge with 107 live Nc-1
tachyzoites at 70 days of gestation. The efficacy against
vertical transmission was examined in groups 4 and 5,
where animals were iv-challenged with 4 × 108 Nc-1 tachy-
zoites at 135 days of gestation. Groups of immunised/non-
challenged (group 1) and non-immunised/non-challenged
(group 6) animals received an inoculum of PBS. The
remaining animals were maintained under field conditions
at the dairy farm and divided into two groups consisting of
immunised heifers (group 7, n = 11) and non-immunised
heifers that received PBS (group 8, n = 10) (Table 1). These
animals became pregnant during the study following the
routine reproductive program in operation on the farm.
None of the animals in these groups was challenged.
Clinical monitoring and sample collection
The safety of the vaccine isolate (Nc-Spain 1H) was de-
termined by daily monitoring of the health status of
immunised heifers (groups 1, 2, 4 and 7) in order to de-
tect possible adverse reactions. Rectal temperatures were
recorded daily for a week after the immunisation and
booster. Animals with temperatures above 39.5 °C were
considered febrile. The ability of the Nc-Spain 1H isolate
to induce foetal death or to be vertically transmitted was
investigated in immunised/non-challenged heifers lo-
cated at the experimental farm (groups 1) and the dairy
farm (group 7). In these groups, foetal viability, detection
of pre-colostral Neospora-specific antibodies in calves
and the presence of parasite DNA and lesions in tissues
from offspring were measured. Additionally, microsatellite
analysis was used to discriminate the challenge isolates
(Nc-1) from the immunisation isolates (Nc-Spain 1H) in
nested-PCR N. caninum-positive tissue samples from
immunised/challenged animals (groups 2 and 4) after
challenge. The impact of the immunisation on the repro-
ductive performance was also studied by comparing the
following reproductive parameters between immunised(groups 1, 2, 4 and 7) and non-immunised heifers (groups
3, 5, 6 and 8): number of AI per conception, fertility at first
AI, age at first AI and age at first calving.
The protective efficacy of the immunisation with live
Nc-Spain 1H tachyzoites against foetal death and vertical
transmission was determined by comparing immunised
and non-immunised heifers after challenge at early
(group 2 vs. group 3) and mid-gestation (group 4 vs.
group 5), respectively. In these groups, rectal tempera-
tures were measured daily for a week after challenge and
then twice weekly until the end of the experiment. Foetal
viability was monitored during gestation; if foetal death
occurred, the presence of parasite DNA and lesions in
foetal tissues were determined. Vertical transmission
was identified in calves after birth by the presence of
Neospora-specific antibodies in pre-colostral blood and
of parasite DNA and lesions in tissue samples.
In the cattle maintained under experimental condi-
tions (groups 1–6), foetal growth and viability was moni-
tored by trans-rectal ultrasonography weekly following
challenge for 45 days then every two weeks until the end
of the pregnancy. When ultrasound examinations de-
tected a non-viable foetus, the animal was examined
24 h later; if the foetal death was confirmed, the dam
was sacrificed with an intravenous overdose of embutra-
mide and mebezonium iodide (T-61®, MDS Animal
Health, Salamanca, Spain). The remaining heifers were
monitored until delivery and slaughtered 1 week after.
In cattle kept under field conditions, foetal viability was
evaluated following the routine reproductive programme
in operation in the dairy farm. Pregnancy status was
determined on days 40–45 and 210–215 of gestation;
between these two tests, the walking activity of the ani-
mal was monitored by pedometers to assess the possibil-
ity of reproductive failure. After calving, these heifers
remained on the farm and were used for dairy pro-
duction. All of the calves from cattle kept under both
experimental and field conditions that were born at full-
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travenous overdose of embutramide and mebezonium
iodide (T-61®, MDS Animal Health, Salamanca, Spain).
Pre-colostral blood samples from calves were collected
after calving in plain evacuated tubes for serology ana-
lysis. Foetuses, calves and heifers were necropsied imme-
diately after euthanasia and tissues were recovered
aseptically. Brain, heart and liver samples from all of the
foetuses and calves (groups 1–8) and brain and placenta
samples from the dams maintained under the experi-
mental conditions (group 1–6) were placed in 10% formol
saline or stored at −80 °C until use for histopathology or
for PCR and microsatellite analyses, respectively.
Blood samples from heifers were collected after immun-
isation every two weeks during the experiment by coccy-
geal venipuncture in plain evacuated and heparinised
tubes for serology and IFNγ analysis, respectively. After
the pregnancy diagnosis, blood samples from heifers that
continued on to the dairy farm were collected in plain
evacuated tubes for serology every 1–3 months from im-
munisation for 22 months.
DNA extraction and PCR
Three different areas from each of the above-mentioned
tissues from foetuses, calves and dams were randomly se-
lected and pooled. Subsequently, 5–8 g of the pool were
homogenised in sterile PBS (dilution 1:2) in a stomacher
(“Masticator” IUL, Barcelona, Spain) for 2 to 5 min.
Placentome samples were minced using a sterile scalpel.
DNA was extracted from aliquots of 50 μL of the homoge-
nised tissues (3 for foetuses and 12 for calves) or three
placental tissue samples (15 mg of tissue per sample) using
the Real Pure Genomic DNA Extraction Kit (Durviz,
Valencia, Spain) following the manufacturer’s instructions.
N. caninum DNA was obtained from 107 tachyzoites. The
concentration of DNA was determined by spectrophotom-
etry and adjusted to 50 ng/μL. A total of 5 μL were used
for PCR amplification.
Nested PCR of the internal transcribed spacer region
of N. caninum was carried out with four oligonucleo-
tides as described by Buxton et al. [12]. A secondary
amplification product was visualised by 1.8% agarose gel
electrophoresis and ethidium bromide staining. DNA
equivalent to 102 tachyzoites was used as the positive
PCR control. To avoid false positive reactions, DNA ex-
traction, PCR sample preparation and electrophoresis
were performed in separate rooms with different sets of
instruments, aerosol barrier tips and disposable gloves.
Moreover, negative control samples were included in
each set of DNA extractions and PCR reactions.
Microsatellites analysis for isolate identification
Approximately 250 ng of DNA extracted from PCR-
positive tissue samples from foetuses, calves and damswas used as the template for the amplification by nested
PCR of 13 microsatellite markers as previously de-
scribed [13,14]. For automated allele sizing, all reverse
primers in the secondary PCR were fluorescently end-
labelled. Amplified products were prepared with HiDi
formamide and Gene Scan-500 (LIZ) Size Standards
(Applied Biosystems, CA, USA). The size of the fluores-
cent PCR product was determined using a 48-capillary
3730 DNA analyser (Applied Biosystems, CA, USA) and
analysed with GeneMapper® V 3.5 Software [14].
Histopathological examination
A histopathological study was carried out on different
sections of the brain and placenta from dams and of the
brain, heart and liver from foetuses and calves using rou-
tine histological methods. Tissues were fixed in 10%
neutral buffered formalin and dehydrated through graded
alcohols before being embedded in paraffin wax and
stained with haematoxylin and eosin. The analysis was
based on the observation of lesions according to previous
descriptions [15-17], and lesions were classified as none de-
tected/unrelated (−), consistent with (+), or characteristic of
(++) bovine neosporosis.
N. caninum-specific antibody responses
Blood samples from heifers and calves were allowed to
clot before centrifugation at 1500 × g for 10 min; the
serum was removed, aliquoted and stored at −20 °C until
required.
Serum samples from heifers were assayed for specific
IgG antibodies using an N. caninum soluble extract
antigen-based ELISA as previously described [18]. Serum
samples were diluted to 1:100 for testing. The anti-
bovine IgG1 and IgG2 monoclonal antibodies (mAbs)
(Laboratorie Service International, France) were diluted
to 1:4000. Serum samples were analysed in duplicate,
and the mean value of the optical density (OD) was con-
verted into a relative index per cent (RIPC) using the
following formula: RIPC = (OD405 sample −OD405 nega-
tive control)/(OD405 positive control −OD405 negative
control) × 100. A RIPC value ≥ 8.2 indicates a positive
result.
N. caninum-specific IgG antibodies from pre-colostral
blood from calves were measured by IFAT as described by
Trees et al. [19]. N. caninum-specific antibodies were mea-
sured in pre-colostral serum samples using a dilution of
1:25 to the endpoint titre [18]. Complete peripheral fluor-
escence of tachyzoites was considered a positive result,
and fluorescence was visualised with a Nikon microscope
(mod. HB-10101AF; mercury lamp).
N. caninum-specific IFNγ responses
Heparinised blood samples were maintained at room
temperature and cultured within 2 h of collection from
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navalin A (10 μg/mL; Sigma) to ensure the ability of the
cells to respond to stimulation and secrete IFNγ, and
with N. caninum Nc-1 isolate soluble antigen (1 μg/mL)
as described previously [7,20]. To assess IFNγ produc-
tion, duplicate plasma samples were tested using a com-
mercial ELISA kit (Bovigam IFNγ kit, CSL, Australia) as
recommended by the manufacturer and using positive
and negative controls provided with the kit. The results
are expressed as OD values.
Statistical analysis
Prior to challenge, rectal temperatures, IgG and IFNγ re-
sponses were compared between immunised (groups 1, 2,
4 and 7) and non-immunised (groups 3, 5, 6 and 8) heifers
using the repeated measures Student’s t-test. After chal-
lenge, differences in these parameters among all the
groups were analysed individually using the repeated mea-
sures one-way ANOVA test. When statistically significant
differences were found, a Duncan Multiple Range test was
applied to examine all possible pairwise comparisons.
Pre-colostral antibody titres and reproductive parameters
between immunised and non-immunised groups were
compared using Student’s t-test. Lesion severity wasFigure 1 Mean rectal temperature of cattle. The rectal temperatures we
(b) with the Nc-Spain 1H isolate, and following challenge with the Nc-1 iso
rectal temperature (°C), and error bars represent the standard deviations foanalysed by the Mann–Whitney U-test. A p-value of less
than 0.05 was considered statistically significant.
Results
Rectal temperature
After immunisation and administration of the booster,
none of the immunised heifers developed hyperthermia
(≥ 39.5 °C). Although slightly higher temperatures were
observed in immunised than in non-immunised animals,
these differences were not significant (groups 1, 2, 4, 7
vs. groups 3, 5, 6, 8; P > 0.05; Figure 1a and b).
Following the challenge at early gestation, both chal-
lenged groups showed a significant rise in temperature in
comparison with non-challenged groups (groups 2, 3 vs.
groups 1, 6; P < 0.001-0.01; Figure 1c). The temperature
response in group 2 (immunised/70-challenged) signi-
ficantly increased at 1–2 days post-challenge (dpc) and
peaked at 39.8 °C 1 dpc (group 2 vs. groups 1, 3, 6; P <
0.001-0.01). In group 3 (non-immunised/70-challenged),
mean temperatures rose on 3–4 dpc and peaked at 39.6 °C
3 dpc (group 3 vs. groups 1, 2, 6; P < 0.001-0.01).
When heifers were challenged at mid-gestation, mean
rectal temperature was higher in challenged groups than
in non-challenged groups from 1 to 3 dpc (groups 4 andre recorded daily for a week following immunisation (a) and booster
late in early (c) and mid-gestation (d). Data are expressed as the mean
r each group.
Rojo-Montejo et al. Veterinary Research 2013, 44:106 Page 6 of 13
http://www.veterinaryresearch.org/content/44/1/1065 vs. groups 1 and 6, P < 0.0001-0.01; Figure 1d). In
group 4 (immunised/135-challenged), the peak mean
temperature was 40.7 °C 1 dpc (group 4 vs. groups 1, 6;
P < 0.0001-0.01), whereas in group 5 (non-immunised/
135-challenged), the mean peak temperature was 40.6 °C
3 dpc (group 5 vs. groups 1, 4, 6; P < 0.0001-0.01).
In contrast to the temperature evolutions that occurred
after immunisation, the challenge infection stimulated a
febrile response that was detected earlier in immunised
animals than in non-immunised animals and that had a
higher magnitude after challenge at 135 days of gestation.
Efficacy of live Nc-Spain 1H immunisation against foetal
death at early gestation
When the efficacy against foetal death was evaluated after
challenge early in gestation, a protection of 50% was ob-
served in group 2 (immunised/70-challenged). In this
group, foetal death was detected in 2 of the 5 heifers at 26
and 97 dpc, whereas in group 3 (non-immunised/70-chal-
lenged), foetal death occurred in 4 of the 5 animals, two at
26 dpc and the others at 77 and 83 dpc. In both chal-
lenged groups, foetal death was associated with the pres-
ence of N. caninum DNA and severe histopathological
changes compatible with N. caninum infection in either
foetal or placenta tissues (Table 2). In the dead foetuses,
lesions mainly consisted of multifocal hepatocellular ne-
crosis in the liver, lymphocytic myocarditis, foci of mono-
nuclear meningoencephalitis and perivascular cuffing inTable 2 Detection of parasite DNA and histopathological cha




















26 14 - + 3/3 Nc-1
97b 15 nd + 0/3 -
Alive nd - - 0/12 -
Alive nd - - 0/12 -




26 17 - + 1/9 na
26 16 - + 3/3 Nc-1
77 18 1:32 * 1/3 na
83 30 - * 1/3 na
Alive nd - - 0/12 -
a Day post-challenge when foetal death was detected by transrectal ultrasonograph
b This foetus was mummified but probably died two months before (around 33 dpc
from this mummified foetus most likely made the detection of parasite DNA unfeas
c Mean IFAT IgG antibody titres in foetal body fluids and in pre-colostral serum coll
d Histopathological lesion severity: none detected (−), consistent with (+), and chara
e Fractions represent number of samples positive by nested PCR/number of sample
f Microsatellite analysis was performed using one sample per nested-PCR-positive ti
tissues analysed (na). The microsatellite profiles of the tissues from which the micro
isolate (Nc-1).brain. In placental tissue samples from dams that ex-
perienced foetal death, severe placentitis consisting of
serum leakage between maternal and foetal tissues, non-
suppurative inflammatory infiltrates in both the maternal
and foetal mesenchyme and areas of haemorrhage and ne-
crosis in the caruncular septa were detected. When lesion
severity was compared between groups 2 and 3, the differ-
ences were found to be non-significant (P > 0.05).
The remaining heifers from groups 2 and 3 that did
not experience foetal death gave birth to live, clinically
normal calves. These calves were seronegative for pre-
colostral N. caninum-specific antibodies, and neither
parasite DNA nor pathological changes were observed in
any examined tissues. In addition, none of the adult
cattle showed N. caninum DNA or histopathological
changes in brain tissue samples.
Efficacy against vertical transmission in immunised
heifers following infection at mid-gestation
After challenge at mid-gestation, one dead foetus was
found in both groups 4 (immunised/135-challenged) and
5 (non-immunised/135-challenged), most likely due to
the high challenge dose by iv route; the remaining foe-
tuses survived throughout the gestation (Table 3). In the
challenged groups, the foetuses died at 25 (group 4) and
47 (group 5) dpc. The presence of parasite DNA was de-
tected in brain tissue samples from both of the dead foe-
tuses, in liver tissue samples from the foetus in group 4nges in foetal and maternal tissues of immunised and
isolate in early gestation
Tissues from foetus/calf Maternal
placentaLiver Heart
HPd DNAe MSf HPd DNAe MSf HPd DNAe MSf
++ 3/3 Nc-1 ++ 3/3 Nc-1 ++ 1/3 Nc-1
++ 0/3 - ++ 0/3 - ++ 1/3 na
- 0/3 - - 0/3 - - 0/3 -
- 0/3 - - 0/3 - - 0/3 -
- 0/3 - - 0/3 - - 0/3 -
- 0/3 - - 0/3 - - 0/3 -
++ 3/3 Nc-1 ++ 3/3 Nc-1 ++ 2/3 na
* 0/3 - * 1/3 na ++ 2/3 na
++ 2/3 na ++ 2/2 na ++ 2/3 na
- 0/3 - - 0/3 - - 0/3 -
y. The remaining foetuses lived until the end of the experiment.
) as indicated by its foetal crown-rump length. The poor quality of the samples
ible. Foetal abdominal fluid for serological analysis could not be collected.
ected after birth in calves born alive.
cteristic of (++) N. caninum infection; * Autolysed.
s examined.
ssue. Microsatellite markers could not be amplified from all of the PCR-positive
satellite markers could be amplified corresponded to that of the challenge
Table 3 Detection of parasite DNA and histopathological changes in tissue samples from foetuses, calves and heifers











Tissues from foetus/calf Maternal placenta
Brain Liver Heart
HPc DNAd MSe HPc DNAd MSe HPc DNAd HPc DNAd MSe




Alive - - 0/12 - - 0/3 - - 0/3 - 1/3 -
Alive 1:100 - 0/12 - - 0/3 - - 0/3 - 0/3 -
Alive 1:200 - 0/12 - - 0/3 - - 0/3 - 0/3 -




47 1:16 ++ 1/3 na ++ 0/3 - ++ 0/3 ++ 2/3 na
Alive 1:800 - 0/12 - - 0/3 - - 0/3 - 0/3 -
Alive 1:1600 - 0/12 - - 0/3 - - 0/3 - 0/3 -
Alive 1:1600 - 0/12 - - 0/3 - - 0/3 - 0/3 -
a Day post-challenge when foetal death was detected by transrectal ultrasonography. The remaining foetuses lived until the end of the experiment.
b Mean IFAT IgG antibody titres in foetal body fluids and in pre-colostral serum collected after birth in calves born alive.
c Histopathological lesion severity: none detected (−), consistent with (+), and characteristic of (++) N. caninum infection; * Autolysed.
d Fractions represent number of samples positive by nested PCR/number of samples examined.
e Microsatellite analysis was performed using one sample per nested-PCR-positive tissue. Microsatellite markers could not be amplified from all of the PCR-positive
tissues analysed (na). The microsatellite profiles of the tissues from which the microsatellite markers could be amplified corresponded to that of the challenge
isolate (Nc-1).
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changes that occurred in dead foetuses after challenge at
day 70 of gestation, the foetal death was associated with
severe lesions in foetal and placental tissues from ani-
mals in both challenged groups that were compatible
with N. caninum infection.
When the protection against vertical transmission was
evaluated, most of the calves from both challenged
groups were found to have precolostral N. caninum-
specific antibodies; however, antibody titres were
significantly lower in animals from the immunised/135-
challenged group (group 4 vs. group 5; P < 0.01; Table 3).
In this group, 3 out of 4 calves had pre-colostral
N. caninum-specific antibodies detected by IFAT at titres
ranging from 1:100 to 1:200. In contrast, all of the calves
from the non-immunised/135-challenged group showed
N. caninum-specific antibody titres ranging from 1:800
to 1:1600. Parasite DNA and lesions compatible with
N. caninum were not detected in tissues from these calves,
and only one placental tissue sample was positive by PCR
in the immunised/135-challenged group (group 4). In
addition, neither N. caninum DNA nor histopathological
changes were found in brain tissues from dams.
Safety of the subcutaneous immunisation with live
Nc-Spain 1H tachyzoites
Following immunisation, nodules at the injection site
were observed in 3 immunised heifers until 3 days after
immunisation and in 2 immunised heifers 1 day after ad-
ministration of the booster.In immunised/non-challenged heifers maintained under
both experimental (group 1) and field conditions (group 7),
most of the calves survived to term and were born clinically
normal with the exception of 2 of 11 calves from the group
maintained in the dairy farm that died as a result of dys-
tocia. Nonetheless, all the calves were seronegative for pre-
colostral Neospora-specific antibodies. In addition, neither
parasite DNA nor lesions were detected in the brain, heart
and liver samples from calves or in the placenta and brain
samples from their dams.
Microsatellite analysis was performed to distinguish the
presence of the challenge isolate (Nc-1) from the immun-
isation isolate (Nc-Spain 1H) in PCR-positive tissues from
foetuses that died during the study in both immunised/
challenged groups (groups 2 and 4). Because of its low
sensitivity [14], amplification of the microsatellite markers
was not achieved for all of the nested-PCR positive sam-
ples. In group 2, this analysis was performed using the
brain, heart and liver tissues from one of the two dead foe-
tuses and the placental tissue from its dam (Table 2). In
group 4, microsatellite sequences were amplified only
from the brain samples of the aborted foetus (Table 3). In
all these samples, only the microsatellite profile corre-
sponding to the challenge isolate (Nc-1) was detected.
Finally, no differences between immunised and non-
immunised groups in routinely evaluated reproductive
parameters in dairy heifers were observed (Table 4), in-
dicating that immunisation with Nc-Spain 1H tachy-
zoites prior to AI did not negatively impact reproductive
performance.
Table 4 Effect of the immunisation with live Nc-Spain 1H









No. stillbirths 2 4
No of AI per
conception a




Age at 1st AI b 16.6 ± 2.2 17.0 ± 1.6
Age at 1st
calving b
27.6 ± 3.0 27.7 ± 2.5
a Data obtained from the immunised heifers (groups 1, 2, 4 and 7, n = 26) and
the non-immunised heifers (groups 3, 5, 6 and 8, n = 22) before challenge
infection.
b Data correspond to the immunised/non-challenged (groups 1 and 7, n = 16)
and non-immunised/non-challenged (groups 6 and 8, n = 13) heifers.
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Prior to challenge, higher antibody levels were detected
between days 18 and 88 after immunisation in immu-
nised/non-challenged heifers than in non-immunised/
non-challenged heifers (group 1, 2, 4 and 7 vs. groups 3,Figure 2 N. caninum-specific IgG responses in cattle kept at the expe
following immunisation with the Nc-Spain 1H isolate prior to AI and challe
Data are expressed as the mean relative index per cent (RIPC), and error ba
standard deviation bars are shown. Positive cut-off≥ 8.2 RIPC. The antibody
lenged group from day 77 post-challenge because most of the heifers wer5, 6 and 8; P < 0.0001; Figure 2); antibody levels in the
immunised/non-challenged heifers reached a peak at day
46 after immunisation. After day 88 post-immunisation
(60 days of gestation), the antibody levels in immunised/
non-challenged heifers moved to the experimental farm
(group 1) decreased to levels that were close to the cut-
off value (RIPC = 8.2). The IgG response of these ani-
mals remained higher than that of the non-immunised/
non-challenged heifers (group 6) until the end of the
experiment, with the exception of day 175, but the dif-
ferences were not significant. The antibody levels in
immunised/non-challenged dams kept under field condi-
tions (group 7) fluctuated around the cut-off from day
124 until day 686 after immunisation (22 months after
immunisation), and generally remained higher in these
animals than in non-immunised/non-challenged animals
(group 8) with the exception of days 159, 400, 442 and
480 after immunisation (P < 0.001; Figure 3).
Following challenge early in gestation, animals in
groups 2 (immunised/70-challenged) and 3 (non-immu-
nised/70 challenged) showed higher antibody production
than those that were not challenged (Figure 2). These
differences were detected in group 2 from 20 dpc on-
wards (group 2 vs. groups 1, 6; P < 0.0001-0.01), and in
group 3 between 20 and 77 dpc (group 3 vs. groups 1, 6;rimental farm. The IgG antibody levels were measured in heifers
nge with the heterologous Nc-1 isolate at early and mid-gestation.
rs represent the standard deviations for each group. Only the upper
concentration could not be measured in non-immunised/70-chal-
e euthanised due to the high foetal mortality detected.
Figure 3 N. caninum-specific IgG responses in cattle maintained at
the dairy farm from day 88 after immunisation. Data are expressed
as the mean relative index per cent (RIPC), and error bars represent the
standard deviations for each group. Positive cut-off≥ 8.2 RIPC.
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animals in group 2 displayed higher antibody levels than
animals in group 3 between 20 and 48 dpc (P < 0.01).
The antibody production in animals from groups chal-
lenged on day 135 of gestation (groups 4 and 5) were sig-
nificantly higher than in animals from non-challenged
groups (groups 1 and 6) (Figure 2). Animals from group 4
(immunised/135-challenged) showed the strongest anti-
body response. In this group, the antibody levels increased
on 12 dpc and remained high until the end of the experi-
ment, peaking between 26 and 61 dpc (group 4 vs. groups
1, 6; P < 0.0001-0.01). Heifers from group 5 (non-immu-
nised/135-challenged) showed significantly higher levels
from 26 dpc onward (group 5 vs. groups 1, 6; P < 0.01).
When comparing both challenged groups, animals from
group 4 showed significantly higher levels than animals
from group 5 from 12 dpc until calving (P < 0.01), exclud-
ing day 103 pc.
In summary, the immunisation with Nc-Spain 1H in-
duced a specific-IgG response that was detectable during
the three months after immunisation. After challenge in
early and mid-gestation, the magnitude of the antibody
response was significantly higher in immunised/challenged
groups than in non-immunised/challenged groups.
IFNγ response after immunisation with live
Nc-Spain 1H tachyzoites
Prior to the challenge, the antigen-specific IFNγ re-
sponse in whole blood culture induced following im-
munisation was evaluated in immunised heifers. In these
animals, IFNγ secretion was detected from day 4 after
immunisation, and their levels of this cytokine remained
significantly higher than those of the non-immunised
heifers until the day of challenge (groups 1, 2 and 4 vs.
groups 3, 5 and 6 on days 4–88 after immunisation;
groups 1 and 4 vs. groups 5 and 6 on days 105–161 afterimmunisation; P < 0.001) and until the end of the study
(group 1 vs. group 6 from day 175 after immunisation
onwards, except days 266 and 294 after immunisation;
P < 0.001) (Figure 4).
The IFNγ values in animals from both groups chal-
lenged early in gestation (groups 2 and 3) were high from
6 dpc until the end of the experiment (Figure 4). Animals
from group 2 (immunised/70-challenged) showed higher
levels than those in non-challenged groups (group 2 vs. 1
on 6–90, 138, 153 and 181 dpc; group 2 vs. group 6 from
6 dpc onward; P < 0.0001-0.05). In group 3 animals (non-
immunised/70-challenged), a significant, specific IFNγ
secretion was detected between 6 and 77 dpc compared to
groups 1 and 6 (P < 0.05). When both challenged groups
(groups 2 and 3) were compared, the differences were not
significant.
After challenge at mid-gestation, strong, specific IFNγ
responses were detected in animals from both challenged
groups (groups 4 and 5, Figure 4). IFNγ secretion was
higher in animals from the immunised/135-challenged
group than in those from the non-challenged (group 4 vs.
group 1, on 48 and 90–118 dpc; group 4 vs. group 6 from
day 26 onwards; P < 0.05). A similar pattern of IFNγ secre-
tion was detected in animals from the non-immunised/
135-challenged group (group 5 vs. group 1 on 26, 48, 90
and 118 dpc; group 5 vs. group 6 from 12 dpc onwards;
P < 0.05). When the levels of IFNγ in animals from groups
4 and 5 were compared, no significant differences were
found.
These data indicate that the production of IFNγ was
immediately stimulated after immunisation with live
Nc-Spain 1H tachyzoites; furthermore, IFNγ levels rose
significantly after challenge and remained at high levels
throughout the gestation period.
Discussion
Vaccine development for bovine neosporosis remains a
high research priority because no cost-effective control
measures are available. Live attenuated vaccines against
other apicomplexan parasites such as Toxoplasma and
Eimeria have successfully induced protective immunity
by stimulation of appropriate cell mediated immune re-
sponses; a live vaccine against bovine neosporosis could
effectively control N. caninum-associated abortions and
congenital transmission. One of the most promising ap-
proaches for live vaccine development against neosporo-
sis involves the use of naturally attenuated N. caninum
isolates. The Nc-Nowra isolate of N. caninum obtained
from the brain of a congenitally infected calf was previ-
ously tested as a potential live vaccine candidate in an
experimental mouse model [21] and a pregnant-bovine
model [3,4] and resulted in a reduction in transplacental
transmission of the parasite and protection against foetal
death, respectively. At the same time, the Nc-Spain 1H
Figure 4 N. caninum-specific IFNγ response in cattle kept at the experimental farm. The production of IFNγ in heifers after immunisation
with the Nc-Spain 1H isolate prior to AI and challenge with the Nc-1 isolate is shown. Data are expressed as the mean optical density (OD), and
error bars represent the standard deviations for each group. Only the upper standard deviation bars are shown.
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didate for its desirable biological characteristics, includ-
ing low invasion and proliferation efficiency in in vitro
assays and reduced virulence and undetectable persist-
ence in mouse and bovine models [5,7].
Appropriate in vitro and animal infection models are
necessary to test the safety and efficacy of a vaccine and
to allow more accurate and cost effective vaccine devel-
opment and candidate selection for clinical trials. In
neosporosis, mouse models provide an initial proof-of-
concept for different vaccine candidates. Consequently,
we previously reported that the immunisation of mice
with live Nc-Spain 1H tachyzoites resulted in a protect-
ive immunity that was able to efficiently control both
congenital and cerebral neosporosis after challenge in-
fection with the virulent Nc-Liv isolate [8]; these results
confirm the suitability of the Nc-Spain 1H isolate as a
promising vaccine candidate against bovine neosporosis.
However, accurate testing of vaccine efficacy ultimately
requires trials using putative vaccine candidates in cattle
as the target species. With this purpose in mind, this
study evaluated whether the immunisation with live Nc-
Spain 1H tachyzoites prior to mating stimulates a pro-
tective response against N. caninum-associated foetal
death and vertical transmission using an immunisation/
challenge pregnant bovine model. This animal model
was based on previous bovine models of infection thatefficiently reproduced the consequences of parasitic in-
fection after challenge at early [22,23] and mid-gestation
[24,25]. Indeed, these bovine models were successfully
used to evaluate the efficacy of potential vaccine candi-
dates in preventing foetal loss or vertical transmission of
the parasite [3,24]. In the present work, the protective
effect of Nc-Spain 1H against foetal death was primarily
evaluated after iv inoculation of 107 live Nc-1 tachyzoites
at 70 days of gestation; a foetal mortality rate of 80%
was observed in the non-immunised/challenged group.
These data agree with previous works in which foetopa-
thy was detected in all of the infected animals after iv in-
oculation of the dam with tachyzoites of Nc-Liv or Nc-1
isolates [22,23]. When the protection of the Nc-Spain
1H isolate against vertical transmission was evaluated, a
higher challenge dose of parasites was inoculated at
mid-gestation in comparison to that inoculated at early
gestation. We increased the challenge dose inoculated
on day 135 of gestation to 4 × 108 live Nc-1 tachyzoites
because infection with 107 live Nc-1 tachyzoites on day
70 of gestation did not induce 100% foetal mortality in
the non-immunised and challenged heifers. This chal-
lenge resulted in efficient vertical transmission of the
parasite, as high N. caninum-specific titres were detected
in all of the calves born to the non-immunised/day-135-
challenged group. Previously, Innes et al. [24] described
a highly valuable vertical transmission bovine model in
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gestation (day 140 of gestation) with 5 × 108 live Nc-1
tachyzoites had high levels N. caninum-specific anti-
bodies. However, the high challenge dose of the present
study appeared to be more potent, inducing not only
vertical transmission in all of the calves born at full term
but also mortality in one foetus at 47 days after chal-
lenge. These differences could be due to the iv challenge
route used in our study that has been reported as indu-
cing greater parasite-associated lesions in the placenta
and foetus than the subcutaneous route [23].
Safety problems are some of the main concerns and
major challenges of live vaccine development. The key
requirements of live attenuated vaccines against bovine
neosporosis are (i) the inability of the vaccine isolate to
be transmitted to the foetus, which could result in abor-
tion or the birth of a congenitally infected animal, and
(ii) the inability of the vaccine isolate to establish infec-
tion in cattle, which could result in the threat of recru-
descence in subsequent pregnancies and, ultimately, the
potential reversion to virulence of the parasite. Because
the Nc-Spain 1H isolate was obtained from the brain of
a clinically healthy but congenitally infected calf, we
conducted an extensive safety evaluation of this isolate
to provide sufficient assurance of its reduced virulence
and persistence in cattle to justify its potential future use
in field cases. To address these questions, we evaluated
the ability of the Nc-Spain 1H to induce foetal death in
the immunised and non-challenged heifers kept under
both experimental and field conditions; in these groups,
all of the foetuses were viable throughout gestation.
Moreover, to rule out the involvement of the vaccine
isolate in foetopathy, a microsatellite analysis, which has
been used to differentiate Neospora isolates in previous
vaccination assays [8,26], was performed in PCR-positive
foetal and placental tissues samples from immunised
and challenged heifers that showed foetal death. In all
cases where the analysis could be performed, only the
microsatellite genotype corresponding to the challenge
isolate Nc-1 [13] was detected. Furthermore, all of the
calves born to immunised and non-challenged heifers
were seronegative at birth. This finding suggests that the
Nc-Spain 1H isolate was unable to induce a detectable
persistent infection in these calves. The failure to obtain
evidence of N. caninum infection in the tissues of any of
the immunised cattle may be explained by the low sensi-
tivity of the techniques used, which were unable to de-
tect small amounts of parasite DNA in these tissues.
Nonetheless, these findings are in agreement with previ-
ously obtained data regarding the pathogenic character-
isation of this isolate, in which Nc-Spain 1H neither
caused foetal death nor was detected in foetal tissues or
the brains of dams [7]. Altogether, these observations
suggest that Nc-Spain 1H is most likely not congenitallytransmitted to progeny when dams are experimentally
inoculated before or during gestation.
Another important aspect of vaccine safety for bovine
neosporosis is the potential negative effect of the inocu-
lation on reproductive performance; indeed, Weber et al.
[4] recently described a reduction in pregnancy rates in
cattle vaccinated with live Nc-Nowra tachyzoites prior
to AI, possibly as a result of an increased cytokine
response that could have negatively affected embryo im-
plantation. In the current work, heifers were sc immu-
nised twice at 4-week intervals with live Nc-Spain 1H
tachyzoites 4 weeks prior to AI. This immunisation
protocol was designed based on previous evidence indi-
cating that congenital transmission of N. caninum does
not occur in cattle primo-infected prior to pregnancy
with live tachyzoites [24]. Moreover, previous studies
demonstrated that N. caninum infection did not inter-
fere with the development of preimplantation stage bo-
vine embryos [27,28]. As expected, the examination of
routinely evaluated reproductive parameters proved that
under the conditions of the present study, the immun-
isation of dairy heifers with live Nc-Spain 1H tachyzoites
did not negatively affect their reproductive performance.
This study demonstrated that immunisation with live
Nc-Spain 1H tachyzoites prior to pregnancy partially
limited foetal death and vertical transmission. Thus, a
protection against foetal death of 50% was observed in
immunised heifers after challenge in early gestation. In
addition, most of the calves born to immunised heifers
challenged at mid-gestation were seropositive at birth,
suggesting that complete protection against vertical
transmission was not achieved. However, precolostral
N. caninum-specific antibodies titres were significantly
lower in animals from the immunised group than in ani-
mals from the non-immunised group, which could indi-
cate a moderate protective response that partially
controlled the number of parasites reaching placenta
and, consequently, limited exposure of the calves to the
parasite in utero. Previous studies using similar immun-
isation/challenge bovine models have shown that im-
munisation of cattle with live N. caninum tachyzoites
results in higher levels of protection than those de-
scribed in the present study after sc immunisation with
live Nc-Spain 1H tachyzoites. On the one hand, iv vac-
cination with live Nc-Nowra tachyzoites completely
prevented foetal loss after a virulent challenge with 107
tachyzoites of the Nc-Liv isolate at 70 day of gestation
[3]; similarly, a recent work on the efficacy of vaccin-
ation with live Nc-Nowra tachyzoites confirmed the high
degree of protection against Neospora-associated foetal
loss conferred by either iv or sc vaccination [4]. On the
other hand, the infection of cattle with live Nc-1 tachyzoites
prior to pregnancy afforded a protection of 100% against
congenital transfer to the foetus after a homologous
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logical characteristics of the N. caninum isolates selected as
candidates for live vaccine, such as their ability to replicate
and actively disseminate, could determine the parasite bur-
den in host tissues. These factors could influence the anti-
genic dose to which the immunised animals are exposed
and, consequently, affect the robustness of the protective
immune response. In this sense, the Nc-Spain 1H isolate,
which previously displayed low in vitro invasion and prolif-
eration capacities [6], could slowly replicate in host tissues
and provide a weak, repeated antigenic stimulus. These
properties could explain the only partial efficacy induced by
the Nc-Spain 1H isolate in comparison with other more
prolific isolates such as Nc-1. Nonetheless, this fact favours
the establishment of a suitable balance between vaccine
safety and efficacy because potential problems related to re-
sidual virulence after vaccination with live tachyzoites could
be mitigated with the use of an attenuated strain. Because
the natural mechanism underlying the low virulence of Nc-
Spain 1H is unknown and no studies regarding the recru-
descence or reversion to virulence of this isolate have been
conducted, further investigations should be performed in
cattle to guarantee the safety of this attenuated isolate in
the natural host. In addition, the primo-infection at early
and mid-gestation achieved in this work by inoculating the
cattle intravenously with notably high parasite doses has
been deemed too aggressive for testing the efficacy of
Nc-Spain 1H in a bovine model; as a result, the vaccine
potency could potentially be underestimated. Accordingly,
the performance of the Nc-Spain 1H-vaccine in the target
population (chronically infected cattle) must be evaluated
in the future.
The immunological response provides evidence of
exposure to live Nc-Spain 1H tachyzoites because all
immunised animals developed N. caninum-specific IgG
and IFNγ responses after parasite inoculation. In par-
ticular, those immunised animals that were not chal-
lenged and maintained under both experimental and
field conditions showed high IgG antibody levels during
the three months after immunisation. Subsequently,
their antibody levels decreased to levels similar to those
observed in the non-immunised heifers, and they fluctu-
ated around the cut-off value until the end of the experi-
ment, suggesting that there was no recrudescence of the
Nc-Spain 1H infection during gestation that might have
led to foetal infection. A similar situation was previously
described when an experimental infection of cattle with
live tachyzoites of this isolate resulted in antibody levels
that declined to undetectable levels from the third week
after infection [7]. However, immunisation induced high
levels of IFNγ production that persisted throughout the
experiment. Williams et al. [3] reported a similar cellular-
mediated immune response in cattle 19 weeks after they
were immunised with live tachyzoites, suggesting thepresence of antigen-specific memory T cells associated
with protection against foetal death in the immunised ani-
mals. It has been widely reported that IFNγ plays a major
role in protection against N. caninum infection by limiting
parasite growth [29,30]. Nevertheless, because a strong,
specific IFNγ response was similarly induced after chal-
lenge in both immunised and non-immunised animals, a
protective immune response could not definitively be as-
sociated with IFNγ levels. Further studies are needed to
investigate the immunological mechanisms involved in the
protective immunity induced by the Nc-Spain 1H isolate.
In conclusion, our data suggest that immunising cattle
with live tachyzoites of the Nc-Spain 1H isolate appears
to be safe and generates a protective immune response
that partially prevents N. caninum–associated abortions
and the vertical transmission of this parasite. We there-
fore support the use of this isolate as a promising vac-
cine candidate for the control of bovine neosporosis.
Further field studies should be conducted to address
whether protective immunity could be induced by Nc-
Spain 1H against neosporosis in naturally infected cattle.
In addition, safety studies should be conducted to evalu-
ate possible residual virulence or recrudescence in the
target animals. Finally, taking into consideration the po-
tential problems related to the efficacy of a live vaccine
product and its short shelf-life, the development of for-
mulations containing stabilisers that preserve the viabil-
ity of tachyzoites would be valuable for commercial
manufacture and distribution of a live vaccine.
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